FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$28.32 B | $28.54 B | $34.12 B | $45.04 B | $65.18 B | $72.25 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$7.31 B | $6.63 B | $7.08 B | $8.42 B | $10.56 B | $11.92 B |
Gross Profit Revenue minus cost of revenue. |
|
$21.01 B | $21.91 B | $27.04 B | $36.62 B | $54.62 B | $60.33 B |
|
Operating Expense
Costs to run business. 
|
|
$13.07 B | $13.26 B | $16.25 B | $19.12 B | $24.92 B | $27.20 B |
Operating Income Profit from operations. |
|
$7.93 B | $8.65 B | $10.79 B | $17.50 B | $29.70 B | $33.14 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$314.40 M | -$268.80 M | -$312.30 M | -$605.40 M | -$642.00 M | -$778.60 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
$1.44 B | $1.52 B | $3.75 B | $4.04 B | $3.32 B | $1.61 B |
Total Other Income (Net) Net non-operating items. |
|
-$1.78 B | -$1.85 B | -$4.23 B | -$4.82 B | -$3.97 B | -$2.01 B |
Income Before Tax Profit before taxes. |
|
$6.16 B | $6.81 B | $6.55 B | $12.68 B | $25.73 B | $31.12 B |
Income Tax Expense Taxes on income. |
|
$573.80 M | $561.60 M | $1.31 B | $2.09 B | $5.09 B | $5.85 B |
|
Net Income
Final profit.
|
|
$5.58 B | $6.24 B | $5.24 B | $10.59 B | $20.64 B | $25.28 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$5.85 | $6.57 | $5.83 | $11.76 | $15.59 | $28.20 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$5.85 | $6.57 | $5.80 | $11.71 | $22.95 | $28.15 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
953.65 M | 950.18 M | 899.38 M | 900.61 M | 898.00 M | 894.50 M |
Diluted Average Shares Outst. Shares including dilution. |
|
953.65 M | 950.18 M | 903.28 M | 904.06 M | 898.00 M | 895.90 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$6.50 B | $7.14 B | $7.04 B | $13.46 B | $26.37 B | $31.52 B |
EBITDA Earnings before interest, tax, D&A. |
|
$8.04 B | $8.66 B | $8.57 B | $15.23 B | $27.94 B | $33.13 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$1.55 B | $1.52 B | $1.53 B | $1.77 B | $1.56 B | $1.61 B |
| Company Report |
FY 2025
Eli Lilly and Company's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
Eli Lilly and Company's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
Eli Lilly and Company's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
Eli Lilly and Company's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
